"Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors." Cancer Biol Ther. 2015;16(1):43-51.
Anne Cress, PhD
Kelvin Pond, PhD
Display on main departmental publications list:
Yes